Eric Topol
American cardiologist and scientistWikipedia
26
MENTIONS
18
EPISODES
18
PODCASTS
Search complete. 26 mentions across 18 episodes found for "Eric Topol".
Sep 19, 2026
Episode 152. Photobiomodulation: Neuronic Helmet Review
R
4:54Roger SeheultHOST
Study identifies mitochondrial dysfunction as the cause of long COVID fatigue.
R
4:58Roger SeheultHOST
You see here from Eric Topol as well, highlighting a number of studies looking at the microbiota and mitochondrial dysfunction as well.
R
5:08Roger SeheultHOST
And way back, even as far back as April of 2020, we made the conclusion based on the studies that reactive oxygen species in the mitochondria was the result of ACE2 not being functional because of the virus.
R
5:23Roger SeheultHOST
And because of that, you had an increase in angiotensin 2 and a decrease in angiotensin 1,7.
How AI is Saving Lives: Fixing a 150-Year-Old Healthcare System with Andy Moye

A
14:35Andy MoyeGUEST
But the first self-driving Tesla that runs into a stop sign, you know, people lose their minds, right? Because the very low tolerance for this sort of machine error, even though the rate of error is so much smaller, right? And in fact, it'd be really interesting for your viewers to go look at this.
A
14:54Andy MoyeGUEST
You know, Eric Topol, who's quite a renowned doctor and scientist here in the U.S., he, along with other physicians, just kind of penned a letter, and I can't remember if it was the New England Journal of Medicine or somewhere else, but had been essentially saying, like, the data around automated cars... is so good that if it was a drug, we would be out of our minds to not prescribe this drug everywhere because we're reducing deaths by 95%.
A
15:19Andy MoyeGUEST
If we wanted to reduce car deaths by 95%, we essentially, everybody stopped driving, get an automated
S
15:26speaker_0NARRATOR
car.
Bob Cordaro Show Hour 2 from September 16, 2026
E
33:00Ed CraneHOST
They also found that 25% of people were taking omega-3, the fish oil, or krill oil supplements, and nearly 20% were taking herbal supplements like ginseng.
E
33:12Ed CraneHOST
Now, Dr. Eric Topol, who's a cardiologist and the founder of the Scripps Research Translational Institute, says there are good reasons to take the supplements, maybe to treat a nutrient deficiency or to prevent birth defects.
E
33:26Ed CraneHOST
But he says most of these are a waste of money, and it's a lot of money.
E
33:31Ed CraneHOST
The global supplement industry valued at $228 billion, with a B.
Marios Georgakis: Why Did Two Major Clinical Trials for Heart Disease Fail?
E
0:01Eric TopolHOST
Okay.
E
0:01Eric TopolHOST
I'm Eric Topol, and this is Ground Truth.
E
0:04Eric TopolHOST
Thrilled that you're joining us today.
E
0:06Eric TopolHOST
I have the real delight to, um, have this discussion with, uh, Marios Georgakis at, uh, the University of Munich, uh, who is a physician scientist, actually a neurologist who studies atherosclerosis, genomics, uh, particularly the cerebrovascular, but he certainly is tuned into the coronary and atherosclerosis anywhere in the body.
The 2026 Lasker Awards, Rheumatoid Arthritis Review, Psilocybin, Narcolepsy, Loberamisal for Ischemic Stroke, and More
L
9:46Linda BrubakerHOST
JAMA's latest episode of JAMA Plus AI Conversations has a fascinating conversation with Drs.
L
9:52Linda BrubakerHOST
Roy Perlis and Eric Topol.
L
9:55Linda BrubakerHOST
They discuss the science of aging, how to think about AI-enabled medicine, including what it will take for AI to move medicine from reactive to predictive.
L
10:05Linda BrubakerHOST
They also talk about why some well-validated imaging AI remains underused while the large language models have spread rapidly and whether AI is actually giving clinicians more time with patients.
From Aging to AI and Beyond: A Conversation With Eric Topol
R
0:00Roy PerlisHOST
[on-hold music] Welcome to JAMA+ AI Conversations.
R
0:08Roy PerlisHOST
I'm Roy Perlis, editor-in-chief of JAMA+ AI, and I'm pleased to welcome today's guest, Dr. Eric Topol, cardiologist and founder and director of the Scripps Research Translational Institute, and one of those people who consistently ends up on the top 25 list of influential people in medicine.
R
0:25Roy PerlisHOST
Dr. Topol's spent a couple of decades now writing about where medicine is going in books like "The Creative Destruction of Medicine," "The Patient Will See You Now," "Deep Medicine," and most recently, "SuperAgers: An Evidence-Based Approach to Longevity," which came out last year and has been on bestseller lists pretty much since then.
R
0:42Roy PerlisHOST
He also writes Ground Truth, a widely read online publication, so he's busy.
22 MINS LATER
E
22:21Eric TopolGUEST
I don't know that many people are talking about this yet, but I do think over time it will become the main agenda.
R
22:28Roy PerlisHOST
It's a lot to look forward to.
R
22:30Roy PerlisHOST
Dr. Eric Topol, thank you for talking with us about aging, about AI, about predicting the future.
R
22:35Roy PerlisHOST
To our listeners, you can find links to Dr. Topol's recent work in the episode notes.
The Megyn Kelly Show: Andrew Huberman on Practical Wellness Tips, the Danger of "If Only" Thinking, and "Protocols" For Life
A
66:01Andrew HubermanGUEST
... which kind of undercut the story.
A
66:03Andrew HubermanGUEST
But anyway, I, listen, I think it's great that he's out there, just like I think it's great that, um, Matt Kaeberlein's out there and, um, Eric Topol.
A
66:09Andrew HubermanGUEST
You need, this is one thing that people really need to understand about health and longevity in the online communities.
A
66:16Andrew HubermanGUEST
In science, in medicine, and I observed this in the, in the world of skateboarding and, and action sports, you need a community, uh, that represent the sort of different extremes, right? In skateboarding we have our Tony Hawk, we had our, my friend Danny Way, who gr- jumped the Great Wall of China.
370. Nicotine Alternative Nootropic Pouch & The Future of Medicine
O
26:48OmarGUEST
There's now been thousands of papers over the past few years showing the value of plasma proteomics.
O
26:53OmarGUEST
There's a paper that came out last week that Eric Topol actually highlighted that gives you your risk of metabolic liver disease, which is basically the hundreds of millions of people end up with liver disease.
O
27:04OmarGUEST
It's where your liver starts to break down.
O
27:06OmarGUEST
It starts to become inflamed and fatty and stops to function.
Microsoft's Peter Lee & Seattle Children's CEO Chris Longhurst | Why humans are still in the loop
C
0:56Christina FarrHOST
He's the president of Microsoft.
C
0:59Christina FarrHOST
And then a very old friend of mine, Chris Longhurst, who has a somewhat new job.
C
1:04Christina FarrHOST
He's now the CEO of Seattle Children's.
C
1:08Christina FarrHOST
So these two are like, you know, who I would be texting in an ideal world whenever any big news comes out about healthcare and AI, because they're just so knowledgeable and really always have just candid thoughts on what's going on in the industry.
25 MINS LATER
P
26:43Peter LeeGUEST
And then the benefit for the organizations is it's again, eliminating coordination friction.
C
26:49Christina FarrHOST
Yeah, I agree with that.
C
26:51Christina FarrHOST
I had a great call with a friend yesterday who's at OpenAI and we talked a lot about prompt engineering and just getting into health systems and really doing some of that training.
C
27:01Christina FarrHOST
Because right now, my physician friends that use the most or clinician friends that use the most AI are also the most technical.
Episode 39: Dr Hatim Abdulhussein on Becoming an AI Professor With No PhD, Setting Up the Topol Fellowship, and Leading a Health Innovation Network
H
13:21Hatim Abdul-HusseinGUEST
Why don't we call this Building a Digital Ready Workforce Fellowship? Let's call it the Topol Fellowship.
H
13:26Hatim Abdul-HusseinGUEST
And so we worked to get a sign off from Eric Topol and from Secretary of State at the time.
H
13:32Hatim Abdul-HusseinGUEST
And the other really good thing was if you get it into policy, it's probably going to happen if there's enough drive around it.
H
13:38Hatim Abdul-HusseinGUEST
And because it was in policy, it was in Topol review, Secretary of State had said that we were going to do it.
5 MINS LATER
J
18:47Jing OuyangHOST
Why AI for you? And did you feel like you were quite early?
H
18:53Hatim Abdul-HusseinGUEST
It at the time felt early because it was a challenge to get people to take you seriously.
H
18:58Hatim Abdul-HusseinGUEST
And I think what really helped was the vision from the Topol review and Eric Topol himself.
H
19:04Hatim Abdul-HusseinGUEST
I mean, there was no doubt that a visionary like that saw what was coming.
8 more episodes mention Eric Topol.
Create an account to see the whole feed, search across every transcript, and follow the entities you care about.